Infrequent genetic alterations of p53, p16 genes and polymorphism in fhit gene in indian myelodysplastic syndrome

Oncology Research

Volumn 11, Issue 2, 1999, Pages 101-104

  Kannan, Karuppiah ^a,e   Tharu, Reeja ^b   Gopinath, P M ^b   Bharadwaj, T P R ^c   Munirajan, Arasampattu K ^d   Tsuchida, Nobuo ^d   Shanmugam, Govindaswamy ^a  

^a MADURAI KAMARAJ UNIVERSITY   (India)

^b UNIVERSITY OF MADRAS   (India)

^c MADRAS MEDICAL COLLEGE   (India)

^d TOKYO MEDICAL AND DENTAL UNIVERSITY   (Japan)

^e WEIZMANN INSTITUTE OF SCIENCE   (Israel)

Author keywords

fhit; Gene alterations; MDS; p16; p53; Tumor suppressor genes

Indexed keywords

ACID ANHYDRIDE HYDROLASE; FRAGILE HISTIDINE TRIAD PROTEIN; PROTEIN; TUMOR PROTEIN;

ARTICLE; ETHNOLOGY; GENETIC POLYMORPHISM; GENETICS; HUMAN; INDIA; MYELODYSPLASTIC SYNDROME; TUMOR SUPPRESSOR GENE;

ACID ANHYDRIDE HYDROLASES; GENES, P16; GENES, P53; HUMANS; INDIA; MYELODYSPLASTIC SYNDROMES; NEOPLASM PROTEINS; POLYMORPHISM, GENETIC; PROTEINS;

EID: 0032612722     PISSN: 09650407     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (11)

1. Adamson, D. J.; Dawson, A. A.; Bennett, B.; King, D. J.; Haites, N. E. p53 mutations in the myelodysplastic syndromes. Br. J. Haematol. 89(1):61-66; 1995.
2. Kamb, A.; Gruis, N. A.; Weaver-Feldhaus, J.; Liu, Q.; Harshman, K.; Tavtigian, S. V.; Stocken, E.; Day, R. S.; Johnson, B. E.; Skolnick, M. H. A cell cycle regulatory potentially involved in genesis of many tumor types. Science 264:436-440; 1994.
3. Druck, T.; Hadaczek, P.; Fu, T. B.; Ohta, M.; Siprashvili, Z.; Baffa, R.; Negrini, M.; Kastury, K.; Veronese, M. L.; Rosen, D.; Rothstein, J.; McCue, P.; Cotticelli, M. G.; Inoue H.; Croce, C. M.; Huebner, K. Structure and expression of the human FHIT gene in normal and tumor cells. Cancer Res. 57:504-512; 1997.
4. Sakai, E.; Tsuchida, N. Most human squamous cell carcinomas in the oral cavity contain mutated p53 tumor suppressor gene. Oncogene 7:927-933; 1992.
5. Tsushita, K.; Hotta, T.; Ichikawa, A.; Saito, H. Mutation of p53 gene does not play a critical role in myelodysplastic syndrome and its transformation to acute leukemia. Br. J. Haematol. 81(3): 456-457; 1992.
6. Hirama, T.; Koeffler, H. P. Role of the cyclin-depdendent kinase inhibitors in the development of cancer. Blood 86:841-854; 1995.
7. Orita, M.; Iwhan, H.; Kanazawa, H.; Hayashi, K.; Sekiya, T. Detection of polymorphism of human DNA by gel electrophoresis as single-strand conformation polymorphism. Proc. Natl. Acad. Sci. USA 86:2766-2770; 1989.
8. Luan, X.; Ramesh, K. H.; Cannizzaro, L. A. FHIT gene transcript alterations occur frequently in myeloproliferative and myelodysplastic diseases. Cytogenet. Cell Genet. 81:183-188; 1998.
9. Carapeti, M.; Aguiar, R. C.; Sill, H.; Goldman, J. M.; Cross, N. C. Aberrant transcripts of the FHIT gene are expressed in normal and leukaemic haemopoietic cells. Br. J. Cancer 78(5):601-605; 1998.
10. Sambrook, J.; Fritsch, E. F.; Maniatis, T. Molecular cloning: A laboratory manual, 2nd ed. Cold Spring Harbor, NY: Cold Spring Harbor Laboratory Press; 1989.
11. Nakamaki, T.; Bartram, C.; Seriu, T.; Kahan, J.; Fukuchi, K.; Tsuruoka, N.; Janssen, J. W. G.; Miller, C. W.; Koeffler, H. P. Molecular analysis of the cyclin-dependent kinase inhibitor genes p15, p16, p18 and p19 in the myelodysplastic syndromes. Leuk. Res. 21(3):235-240; 1997.